The present review will discuss the functional role of the most-studied MAP4K member, MAP4K4, in inflammatory and malignant diseases, including glioblastoma, colon, prostate, and pancreatic cancers and cancer-associated cachexia, and its possible use in targeted therapy. This evidence concerns the gene MAP4K4 and Cachexia.